Cellular RIPK1-caspase-8-dependent apoptosis was enhanced by the use of SIRT1 inhibitors, suggesting that RIPK1 may promote apoptosis upon acetylation, thus affecting the biological behavior of tumor cells and influencing tumor development [134]. Here, CASP8 is linked to neoplasm.